South Asia Journal Watch: 14 November 2026

South Asia Journal Watch

South Asia Journal Watch

14 November 2026

Microbiology, infectious disease, AMR and infection-control papers from India and South Asia added to PubMed on 11 to 13 November 2026 and not covered in earlier issues.

Lead articles

Tuberculosis · Case-finding · The Lancet Global Health

Geographical targeting of active case-finding for tuberculosis in Pakistan using artificial intelligence software (SPOT-TB): a pragmatic, stepped wedge, cluster-randomised control trial

The Lancet Global Health · doi:10.1016/j.langlo.2026.104090 · PubMed 43020100

What
A pragmatic trial testing whether artificial intelligence (AI)-guided geographical targeting of community active case-finding camps increases tuberculosis detection compared with conventional site selection within Pakistan’s National TB Control Program.
Design
Stepped wedge, cluster-randomised trial across all four provinces of Pakistan, embedded in Global Fund-supported active case-finding. 30 mobile x-ray van teams in 68 districts were randomised to move from conventional site selection (field knowledge, experience, historical data) to targeting with the MATCH-AI software. Primary outcome: camp positivity yield (bacteriologically confirmed tuberculosis per camp). Intention-to-treat primary analysis; a validated per-protocol analysis included camps within 5 km of AI-recommended locations (NCT06017843).
Key findings
Between Aug 1, 2023, and Sept 28, 2024, 3936 camps were held (2046 control, 1890 intervention), screening 269 254 individuals. By intention to treat, camp positivity yield was 7% higher with AI targeting but not statistically significant (adjusted risk ratio 1·07, 95% CI 0·94-1·22; p=0·27). In the validated per-protocol analysis, yield was 32% higher (1·32, 1·12-1·54; p<0·0001). Yields were highest in districts with moderate baseline yields and in rural districts.
Limitations
The intention-to-treat result was not significant. Routine programmatic data did not capture all implementation or process-quality indicators, limiting assessment of fidelity and variation across sites.
Relevance to South Asia
The authors conclude that AI-guided targeting could improve the efficiency of community-based tuberculosis case-finding in high-burden countries.

AMR · Shigella · Journal of Medical Microbiology

In vitro activity of oral antibiotics against extensively drug-resistant Shigella isolates: a pharmacokinetic/pharmacodynamic perspective on the intracellular pathogenesis paradigm

Journal of Medical Microbiology · doi:10.1099/jmm.0.002213 · PubMed 43023838

What
A Christian Medical College, Vellore, study of molecular resistance profiles, in vitro activity and pharmacokinetic-pharmacodynamic (PK/PD) applicability of candidate oral antibiotics against extensively drug-resistant (XDR) Shigella.
Design
Between 2010 and March 2025, 1,823 non-duplicate clinical Shigella isolates were screened at a tertiary care centre in South India; 52 met XDR criteria (azithromycin MIC ≥32 mg/l, ceftriaxone MIC >4 mg/l, ciprofloxacin MIC >1 mg/l). PCR targeted β-lactamase, mphA, msrE, ermB, qnrS and qnrB genes. MICs of amoxicillin-clavulanate, cefpodoxime-clavulanate, fosfomycin, mecillinam and faropenem were determined by broth or agar dilution and interpreted with CLSI M100 (2025) or literature-derived PK/PD thresholds.
Key findings
β-Lactamase genes and mphA were detected in 96.2% of isolates and qnrS/qnrB in 53.8%. Cefpodoxime-clavulanate and faropenem showed 100% susceptibility, followed by fosfomycin (98.1%) and mecillinam (94.2%). MIC50/MIC90 (mg/l) were 0.5/0.5 for faropenem, 0.25/2 for mecillinam and 0.25/2 for cefpodoxime-clavulanate. PK/PD analysis suggested several agents lacked sustained intracellular exposure despite favourable MICs.
Limitations
Single centre and 52 XDR isolates; intracellular adequacy was inferred from PK/PD analysis, not clinical outcomes.
Relevance to India
The authors state that favourable in vitro susceptibility did not consistently translate into predicted intracellular adequacy, and support PK/PD-informed assessment beyond MIC-based interpretation for XDR shigellosis.

More from the journals

AMR & antimicrobials

TB & mycobacteria

Vector-borne & zoonoses

Vaccines & virology

Clinical infection, HAI & public health

Items are summaries of published abstracts and are not clinical advice. Readers should consult the original article. Figures are quoted as reported in each abstract.

Leave a Reply

Your email address will not be published. Required fields are marked *